凱普生物(300639.SZ):擬投資15.12億元建凱普醫學科學園
格隆匯5月11日丨凱普生物(300639.SZ)公佈,公司於2022年5月11日召開第四屆董事會第三十五次會議和第四屆監事會第三十次會議,審議通過了《關於公司擬投資建設凱普醫學科學園的議案》。
生物經濟已成為國家技術戰略科技力量和推動經濟高質量發展的強勁動力,新冠疫情推動生物科技產業加速升級。為順應國家“十四五”生物經濟系列發展規劃關於大力開發分子診斷等先進診斷技術和產品,加快產品創新和產業化技術突破,推動醫藥製造能力系統升級等要求,結合公司實際情況和市場的需求,公司擬在廣東省潮州市潮安區大嶺山產業園(公司尚未取得目標土地使用權,需通過參與政府招拍掛出讓的方式取得)投資建設凱普醫學科學園,充分發揮公司在生物科技領域的影響力以及對上下游配套產業鏈的帶動作用,聚焦大健康領域,圍繞體外診斷全產業鏈開展建設,打造高端生物醫學實驗耗材及體外診斷原材料生產基地、新冠防疫檢測配套試劑生產基地、生物儀器研發智造基地、新型消毒防護用品生產基地、包裝材料生產基地、凱普創新研究中心、檢驗護理等醫療人才培訓及高端學術交流中心、生物科技產業鏈企業引進及孵化服務基地以及其他生產生活相關配套設施等,積極向上下游拓展,增強產業鏈自主可控能力,降低成本提升利潤水平,全面提升優質產能。該項目預計總投資約15.12億元,所需用地約235畝(具體用地面積以實際情況為準)。
此次公司擬圍繞體外診斷全產業鏈,充分發揮公司在生物科技領域的影響力以及上下游配套產業鏈的帶動作用,投資建設凱普醫學科學園,積極向上下游拓展,增強產業鏈自主可控能力,降低成本提升利潤水平、全面提升優質產能,對公司產業佈局及未來發展具有積極意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.